This May Be the Best News in Pfizer's Earnings Report

·4 min read
This May Be the Best News in Pfizer's Earnings Report

The company raised its 2021 sales forecast for its coronavirus vaccine by 73%. Pfizer also lifted its annual revenue guidance -- and raised guidance excluding coronavirus vaccine sales. Investors looking for income should be happy too: Pfizer is maintaining its dividend level even after Viatris -- the result of its Upjohn spinoff -- begins paying one.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting